Related Experiment Video
Updated: Aug 10, 2026

Study of Experimental Organ Donation Models for Lung Transplantation
Published on: March 15, 2024
Restricting living-donor-cadaver-donor exchanges to ensure that standard blood type O wait-list candidates benefit
Lainie Friedman Ross1, Stefanos Zenios
1Department of Pediatrics, Section of General Pediatrics, University of Chicago, Chicago, IL 60637, USA. lross@uchicago.edu
Region 1 of the United Network for Organ Sharing created a consortium that allows a person waiting for a kidney transplant to take a higher priority on the list when a relative makes a living donation to another waiting recipient. This can be done by exchanging kidneys between two living-donor-recipient pairs (living paired exchange) or by exchanging kidneys through a living-donor-cadaver-donor exchange (list paired exchange). In this article, the authors argue that a list paired exchange that allows ABO-incompatible donor-recipient pairs to participate is morally problematic because it harms standard blood type O wait-list candidates who already have the longest waiting times. We propose and model restrictions on who can participate in such exchanges to ensure that the standard blood type O wait-list candidates are made better off. We restrict list paired exchanges to (1) ABO-incompatibilities between living donors and recipients for potential recipients with blood types A, B, and AB; and (2) all recipients who have an ABO-compatible, positive-crossmatch living donor. Although these restrictions do not allow for the maximization of the number of organs potentially procured by means of list paired exchanges, they increase the number of kidneys available in an ethically fair manner.
Region 1 of the United Network for Organ Sharing created a consortium that allows a person waiting for a kidney transplant to take a higher priority on the list when a relative makes a living donation to another waiting recipient. This can be done by exchanging kidneys between two living-donor-recipient pairs (living paired exchange) or by exchanging kidneys through a living-donor-cadaver-donor exchange (list paired exchange). In this article, the authors argue that a list paired exchange that allows ABO-incompatible donor-recipient pairs to participate is morally problematic because it harms standard blood type O wait-list candidates who already have the longest waiting times. We propose and model restrictions on who can participate in such exchanges to ensure that the standard blood type O wait-list candidates are made better off. We restrict list paired exchanges to (1) ABO-incompatibilities between living donors and recipients for potential recipients with blood types A, B, and AB; and (2) all recipients who have an ABO-compatible, positive-crossmatch living donor. Although these restrictions do not allow for the maximization of the number of organs potentially procured by means of list paired exchanges, they increase the number of kidneys available in an ethically fair manner.
More Related Videos
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
07:08A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
Published on: June 6, 2025
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure